Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
AOTI, Inc. ( (GB:AOTI) ) just unveiled an update.
AOTI, Inc. announced the availability of its 2024 Annual Report and Financial Statements, along with the 2025 Notice of Annual General Meeting, on its website. The AGM is scheduled for June 25, 2025, in London, and shareholders are encouraged to vote by proxy. The announcement highlights the company’s ongoing commitment to transparency and shareholder engagement, potentially impacting its market positioning and stakeholder relations.
More about AOTI, Inc.
AOTI, Inc., founded in 2006, is a medical technology company based in Oceanside, California, US, and Galway, Ireland. The company specializes in innovative solutions for severe and chronic wounds, focusing on reducing healthcare costs and improving patient quality of life. Its flagship product, the patented non-invasive Topical Wound Oxygen (TWO2®) therapy, has shown significant effectiveness in reducing the recurrence of Diabetic Foot Ulcers and lowering hospitalizations and amputations.
Average Trading Volume: 46,897
Technical Sentiment Signal: Strong Sell
Current Market Cap: £87.75M
Learn more about AOTI stock on TipRanks’ Stock Analysis page.